Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
ABCS
acetylcholine receptor antibody
acoustic neurinoma, bilateral
acquired immunodeficiency syndrome
addiction, heroin
adrenoleukodystrophy
adrenomyeloneuropathy
advances in neurology
adverse drug reaction
alcohol
Alzheimer's disease
Alzheimer's disease, treating associated medical problems in
Alzheimer's disease, treatment of
amphotericin B
amyloid angiopathy, cerebral
amyloid beta protein
angiotensin-converting enzyme, inhibitors
anterior tibial muscle weakness
anti HMGCR antibody
anticoagulant, complications of
anticoagulant, contraindications
anticoagulant, discontinuation
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
anticonvulsants, blood level determination of
antihypertensive
antioxidant
antiviral agents
arthralgia
aspartate aminotransferase
aspirin
asymptomatic
ataxia
atherosclerosis, generalized
atorvastatin
atrial fibrillation
attention deficit disorder with hyperactivity
autoantibodies
autoimmune disease
azidodeoxythymidine
Babinski sign
bacterial infection
behavioral disorder
bezafibrate
biologic markers
blood pressure
blood pressure, control
blood pressure, lowering
brain atrophy
brain natriuretic peptide
calcium antagonist
carbenoxolone
cardiomyopathy
cardiovascular disease
carotid artery
carotid artery atherosclerosis
carotid artery atherosclerosis, pathogenesis
carotid artery atherosclerosis, regression
carotid artery disease
carotid artery disease, asymptomatic
carotid artery disease, medical management
carotid artery disease, noninvasive evaluation of
carotid artery intima-media thickness
carotid artery plaque
carotid artery stenosis
carotid artery stenosis, intracranial
carotid artery stenosis, risk of stroke with
carotid artery stenosis, surgical treatment
carotid artery stenosis, symptomatic
catalepsy
CD4 counts
cerebellar degeneration
cerebral atherosclerosis
cerebral cortical atrophy
cerebral infarction
cerebral infarction, hemorrhagic
cerebral ischemia
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, classification
cerebrovascular accident, model for predicting risk of
cerebrovascular accident, pathophysiology
cerebrovascular accident, prevention of
cerebrovascular accident, primary prevention
cerebrovascular accident, prognosis in
cerebrovascular accident, racial differences
cerebrovascular accident, recurrent
cerebrovascular accident, secondary prevention
cerebrovascular accident, severity
cerebrovascular accident, sex distribution
cerebrovascular accident, volume
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular disease
cerebrovascular disease, risk factors in
cerebrovascular disease, treatment of
cerivastatin
children
chloroquine
cholesterol
cholesterol, HDL
cholesterol, LDL
choreoathetosis
chromosome 12
cigarette smoking
Clinical Pathologic Conference(C.P.C.)
clofibrate
clopidogrel
coenzyme Q10
cognition
colchicine
complications
contraindications
controversies in neurology
coronary artery disease
corpus callosum, lesion of
cost effectiveness
coumarin
creatine kinase
creatine phosphokinase(CPK)elevated
decision analysis
dementia
dementia, presenile
dementia, prevention of
dementia, treatment of
developmental disability
diabetes mellitus
diarrhea
diet
difficulty going down stairs
dipyridamole
disability, neurological
disease modifying agents
distal muscle weakness
diuretic
drug abuse
drug induced neurologic disorders
drug interactions
drug withdrawal
duplex ultrasound
dysarthria
dysphagia
dystonia
efficacy
electrocardiogram, abnormal
electromyogram
embolism, platelet
endarterectomy, carotid
endarterectomy, carotid-complications of
endarterectomy, carotid-indications for
endarterectomy, carotid-long term results
endarterectomy, carotid-morbidity and mortality with
endarterectomy, carotid-timing after stroke
endovascular therapy
enzyme inhibition
enzyme, induction
enzyme, muscle disease
eosinophilia
eosinophilic fasciitis
epidemiology of neurology
epsilon-aminocaproic acid(E.A.C.A.)
evidence-based research
exercise
exome sequencing
ezetimibe
falling
fat redistribution
fatigue
fibrate
fibrillations
gadolinium
gait disorder
gaze palsy, supranuclear
gemfibrozil
gender
gene mutation
genetic neurologic disorders
genetic testing
genotype
glucose tolerance test, abnormal
headache
hearing loss
hemosiderosis of CNS, superficial
hepatosplenomegaly
high arched feet
hip flexor weakness
histopathology
HMGcoA reductase inhibitors
homocysteine, serum
hospitalization
human diploid cell rabies vaccine
human immunodeficiency virus type 1
hyperbilirubinemia
hypercholesterolemia
hyperglycemia
hyperlipidemia
hyperreflexia
hypertension
hypertriglyceridemia
hypokalemia
hyporeflexia
hypothyroidism
iatrogenic neurologic disorders
imbalance
immunomodulation
immunosuppressive agents
incoordination
indinavir
intellectual deficit
intelligence quotient
interferon
interferon beta 1-a
intracerebral hemorrhage
intracerebral hemorrhage, lobar
intracerebral hemorrhage, recurrent
ipecac
jaundice
Krabbe's disease
leg weakness, bilateral
leuko-araiosis
leukodystrophy
life expectancy
lifestyle
lifestyle
lipid lowering agent
lipid storage disorder of CNS
lipids
lipoproteins
liquorice
lithium
liver function enzymes
lovastatin
lysosomal storage disease
medication withdrawal
microangiopathy, brain
microhemorrhage, intracerebral
middle cerebral artery atherosclerosis
Mini Mental Status Examination
misdiagnosis
mortality
movement disorder
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, mismatch between perfusion/diffusion
MRI, muscle
multiple sclerosis
multiple sclerosis, relapsing
multiple sclerosis, treatment of
multiple sclerosis, worsening
muscle biopsy
muscle cramp
muscle pain
muscle strength, testing
muscle swelling
muscle tenderness
muscle weakness
muscle weakness, causes of
muscle weakness, proximal
myasthenia gravis
myasthenia gravis, exacerbation
myasthenic syndrome
myocardial infarction
myoglobinuria
myopathy
myopathy, acute
myopathy, alcoholic
myopathy, autoimmune
myopathy, drug-induced
myopathy, hypokalemic
myopathy, necrotizing
myopathy, necrotizing, autoimmune
myopathy, necrotizing, immune-mediated
myopathy, proximal
myopathy, steroid induced
myopathy, steroid responsive
myopathy, toxic
myositis
myotonic discharges
nausea and vomiting
neck weakness
negative
nelfinavir
neoplasm, primary of CNS-intraventricular
neurofibromatosis 1
neuroleptic
neurologic disease, diagnoses of
neuropathology
neuropathy
neuropathy, demyelinating
neuropathy, iatrogenic
neuropathy, medication induced
neuropathy, peripheral
neuropathy, toxic
neuroprotective agents
Niemann-Pick disease
NIH stroke scale
nonsteroidal anti-inflammatory drug
old age, neurology of
omega-3 fatty acids
osteoporosis
pain
pain, flank
pain, leg
paresthesias
Parkinson disease
Parkinson disease, drug induced
Parkinson disease, unmasked
parvovirus
patient information and support
perhexiline maleate
pes cavus
physical activity
platelet inhibiting drugs
platelet inhibiting drugs, combined
platelet inhibiting drugs, contraindications
polyneuropathy
polypharmacy
practice guidelines
pravastatin
prevention of neurologic disorders
prognosis
progressive neurologic disorder
protease inhibitor, HIV-1
psychiatric problems in neurologic disorders
psychological testing
psychosis
quality of life
recurrent
renal failure
renal failure, acute
renal stones
respiratory failure
retrovirus
reversible neurologic disorder
review article
rhabdomyolysis
rifampin
risk factor calculator
risk factors
risk factors, modification
risk-benefit assessment
ritonavir
Rosuvastatin
safety
salivation, excessive
saquinavir
screening
seizure
selective serotonin reuptake inhibitors
serum alanine aminotransferase
sex reassignment surgery
simvastatin
small vessel disease
SPARCL trial
splenomegaly
standing difficulty
statin therapy
statin therapy, discontinuation
statin therapy, dose
stent, carotid artery
steroid
sulfinpyrazone
symptomatic
tandem gait, ataxic
the million hearts initiative
toe walking
transgender
transient ischemic attack
transient ischemic attack, evaluation
transient ischemic attack, recurrent
transient ischemic attack, treatment of
transient neurologic deficit
transluminal angioplasty, intracranial
treatment of neurologic disorder
tremor
tremor, intention
triglycerides
tripping
ultrasonography
ultrasonography, carotid artery
urine, dark
vertebral-basilar artery, atherosclerosis
vincristine neurotoxicity
viral infection
viral load
vitamin supplementation
walking, delayed
walking, difficulty with
weakness
weakness, generalized
weakness, progressive
weakness, proximal
weight loss
white matter disease
wide based gait
workup
Showing articles 1900 to 1950 of 3646 << Previous Next >>

Neurology and the Skin
JNNP 66:417-430, Hurko,O.&Provost,T.T., 1999

Neuroendocrine Lung Tumors and Disorders of the Neuromuscular Junction
Neurol 52:1490-1491, Burns,T.M.,et al, 1999

Brain Tumors in Children
Arch Neurol 56:421-425, Packer,R.J., 1999

Current Treatment of Oligodendrogliomas
Arch Neurol 56:434-436, Perry,J.R.,et al, 1999

Superselective Intraarterial Fibrinolysis in Central Retinal Artery Occlusion
AJNR 20:565-567, Padolecchia,R.,et al, 1999

Acute and Reversible Parkinsonism Due to Organophosphate Pesticide Intoxication, Five Cases
Neurol 52:1467-1471, Bhatt,M.H.,et al, 1999

Prevention of Postherpetic Neuralgia
Lancet 353:1636-1637, Dworkin,R.H., 1999

Association of Hyperdense Middle Cerebral Artery Sign with Clinical Outcome in Patients Treated with Tissue Plasminogen Activator
Stroke 30:769-772, Manelfe,C.,et al, 1999

Contrast Agent Neurotoxicity Presenting as Subarachnoid Hemorrhage
Neurol 52:1503-1505, Sharp,S.,et al, 1999

Evaluation of Early Reperfusion and IV tPA Therapy Using Diffuion- and Perfusion-Weighted MRI
Neurol 52:1792-1798,1733, Marks,M.P.,et al, 1999

Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
NEJM 340:1781-1787, Kwiatkowski,T.G.,et al, 1999

Progression of Mass Effect After Intracerebral Hemorrhage
Stroke 30:1167-1173, Zazulia,A.R.,et al, 1999

Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
NEJM 340:757-763,801, The Parkinson Study Group, 1999

CT Angiography and Doppler Sonography for Emergency Assessment in Acute Basilar Artery Ischemia
Stroke 30:606-612, Brandt,T.,et al, 1999

Churg-Strauss Syndrome, Clinical Study and Long-Term Follow-Up of 96 Patients
Medicine 78:26-37, Guillevin,L.,et al, 1999

Diagnosis and Treatment of Ischemic Stroke
Am J Med 106:211-221, Alberts,M.J., 1999

Acute Vertebrobasilar Occlusion:Treatment with High-Dose Intraarterial Urokinase
AJR 172:709-712, Hoffman,A.I.,et al, 1999

Interferon-alpha 2a Reduces MRI Disease Activity in Relapsing-Remitting Multiple Sclerosis
Neurol 52:1049-1056, Myhr,K.M.,et al, 1999

Ibuprofen Treatment Versus Gradual Introduction of Interferon B-1b in patients with MS
Neurol 52:1893-1895, Rice,G.P.A.,et al, 1999

Salvage Chemotherapy with Tamoxifen for Recurrent Anaplastic Astrocytomas
Arch Neurol 56:703-708, Chamberlain,M.C.&Kormanik,P.A., 1999

Applications of Diffusion-Perfusion Magnetic Resonance Imaging in Acute Ischemic Stroke
Neurol 52:1750-1756,1733, Fisher,M.&Albers,G.W., 1999

Low-Density Lipoprotein Cholesterol and the Risk of Dementia with Stroke
JAMA 282:254-260, Moroney,J.T.,et al, 1999

Initial Clinical Experience with IV Tissue Plasminogen Activator for Acute Ischemic Stroke:A Multicenter Survey
Neurol 53:424-427, Tanne,D.,et al, 1999

Consent Issues in the Management of Cerebrovascular Diseases, A Position Paper of the American Academy of Neurology Ethics and Humanities Subcommittee
Neurol 53:9-11, , 1999

High Incidence of Secondary Brain Tumours after Radiotherapy and Antimetabolites
Lancet 354:34-39, Relling,M.V.,et al, 1999

Intraarterial Thrombolysis for Treatment of Acute Stroke:Experience in 26 Patients with Long-Term Follow-Up
AJNR 20:1291-1299, 1194, Jahan,R.,et al, 1999

Magnetic Resonance Imaging Results of the PRISMS Trial:A Randomized, Double-Blind, Placebo-Controlled Study of Interferon-B1a in Relapsing-Remitting Multiple Scleroosis
Ann Neurol 46:197-206, Li,D.K.B.,et al, 1999

Clinicopath Conf,Multifocal Inflammatory Leukoencephalopathy Related to Combination Chemo with Fluorouracil/levamisole
NEJM 341:512-519, Case 24-1999, 1999

Prevalence of Peripheral Neuropathy in Injection Drug Users
Neurol 53:592-597, Berger,A.R.,et al, 1999

Agreement and Variability in the Interpretation of Early CT Changes in Stroke Patients Qualifying for Intravenous rtPA Therapy
Stroke 30:1528-1533, Grotta,J.C.,et al, 1999

Isolated Angiitis of the Central Nervous System:Lack of Inflammation after Long-Term Treatment
Neurol 52:196-199, Reimer,G.,et al, 1999

Cerebral Venous Thrombosis,Combined Intrathrombus rtPA and Intravenous Heparin
Stroke 30:489-494,481, Frey,J.L.,et al, 1999

Cerebral Venous Thrombosis,Nothing,Heparin,or Local Thrombolysis?
Stroke 30:481-483, Bousser,M-G, 1999

Evaluation of Early Computed Tomographic Findings in Acute Ischemic Stroke
Stroke 30:389-392, Marks,M.P.,et al, 1999

"Telestroke",The Application of Telemedicine for Stroke
Stroke 30:464-469, Levine,S.R.&Gorman,M., 1999

Ischemic Core and Penumbra in Human Stroke
Stroke 30:93-99, Kaufmann,A.M.,et al, 1999

Intra-Arterial rtPA Treatment of Stroke Assessed by Diffusion- and Perfusion-Weighted MRI
Stroke 30:678-680, Lansberg,M.G.,et al, 1999

Early Clinical and Radiological Predictors of Fatal Brain Swelling in Ischemic Stroke
Stroke 30:287-292, Krieger,D.W.,et al, 1999

Risk Factor Modification in Stroke Prevention,The Experience of a Stroke Clinic
Stroke 30:16-20, Joseph,L.N.,et al, 1999

The Effects of Mannitol on Cerebral Edema after Large Hemispheric Cerebral Infarct
Neurol 52:583-587, Manno,E.M.,et al, 1999

Serum Glucose Level and Diabetes Predict Tissue Plasminogen Activator-Related Intracerebral Hemorrhage in Acute Ischemic Stroke
Stroke 30:34-39, Demchuk,A.M.,et al, 1999

Multiple Sclerosis,Therapeutic Update
Arch Neurol 56:277-280, Tselis,A.C.&Lisak,R.P., 1999

Herpes Varicella Zoster Encephalitis in Immunocompromised Patients
Neurol 52:193-195, Weaver,S.,et al, 1999

Cerebral Tumor-Like American Trypanosomiasis in Acquired Immunodeficiency Syndrome
Ann Neurol 45:403-406, Pagano,M.A.,et al, 1999

Progressive Multifocal Leukoencephalopathy in a 15-Year-Old Boy with Scleroderma and Secondary Amyloidosis
Pediatrics 103:1475-1479, Hahn,J.S.,et al, 1999

HAART Improves Prognosis in HIV-Associated Progressive Multifocal Leukoencephalopathy
Neurol 52:623-625,440, Clifford,D.B.,et al, 1999

Drug-Induced Hypoglycemic Coma in 102 Diabetic Patients
Arch Int Med 159:281-284, Ben-Ami,H.,et al, 1999

Severe Anaphylaxis with Recombinant Interferon Beta
Neurol 52:425, Corona,T.,et al, 1999

Control of Primary Angiitis of the CNS Associated with Cerebral Amyloid Angiopathy by Cyclophosphamide Alone
Neurol 52:660-662, Fountain,N.B.&Lopes,B.S., 1999

Course and Treatment of Myasthenia Gravis During Pregnancy
Neurol 52:447-452, Batocchi,A.P.,et al, 1999



Showing articles 1900 to 1950 of 3646 << Previous Next >>